$VTR · Ventas, Inc.
Ventas filed its Q3 FY2026 10-Q, reporting total revenues of $1.832B (+23.0% YoY), GAAP EPS of $0.13, and net income of $67.3M. The SHOP segment was the standout, with resident fees and services reaching $1.45B for the quarter and nine-month SHOP NOI surging 41.6% to $1.208B. The company issued significant equity during the period, with shares outstanding rising to 528.8M from 474.9M at year-end, while simultaneously reducing total debt from $13.01B to $12.44B.
- Total revenues hit $1.832B in Q3 FY2026, up 23.0% YoY from $1.489B
- SHOP segment NOI jumped 41.6% to $1.208B for the nine months, powered by resident fees growth
- GAAP EPS of $0.13 vs $0.15 in Q3 2025, with net income of $67.3M
- Common shares outstanding rose to 528.8M from 474.9M at year-end 2025 after $3.9B in equity issuance
- Total debt declined to $12.44B from $13.01B at year-end, with $1.81B in repayments
Extended-hours trading shows VTR at $82.04, up 1.20% from the regular-session close of $81.07, suggesting the market is rewarding the 23% revenue growth and SHOP segment strength despite the slight EPS decline.
Ventas's 23% revenue growth and 41.6% SHOP NOI surge signal that the senior housing recovery is accelerating faster than the market expected, even as equity dilution tempers per-share results.
Ventas's 23% revenue growth far outpaces typical healthcare REIT peers, with the SHOP (senior housing operating portfolio) segment driving nearly all the upside as the sector benefits from demographic tailwinds and post-pandemic occupancy recovery.
SHOP segment operating expenses consumed 70.3% of resident fees ($1.02B of $1.45B), leaving narrow margin room if labor or care costs escalate. The $20.6M loss from unconsolidated entities in the nine-month period vs. a $12.2M gain last year signals stress in joint-venture investments.